Inovio Pharmaceuticals Inc (NASDAQ: INO) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company released a key clinical update late yesterday. Today, we’ll talk about the update, what we’re seeing from the stock, and what we’ll be watching for with regard to INO ahead.
INO Releases Clinical Update
As mentioned above, Inovio Pharmaceuticals is having an incredibly strong start to the trading session this morning after the company released a key update. In a press release issued late yesterday, the company announced that its synthetic vaccine approach generated broad protective antibody responses against all major deadly strains of H1 influenza viruses.